---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-002850"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2026-01-20T23:59:59+00:00"
generated_at: "2026-05-16T09:36:42.397723+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Indaptus cuts co-CEO and CSO salaries to $60K/year; director rescinds resignation

## Summary
- Co-CEO Jeffrey A. Meckler and CSO Michael J. Newman salaries reduced to $60,000 per annum effective Jan 15, 2026.
- Director Anthony Maddaluna rescinded his prior resignation and will remain on the Board, including Compensation and Nominating committees.
- Salary adjustments are for the remainder of the 2026 calendar year and follow prior employment modifications from Dec 2025.
- The reductions are part of a cost-saving measure tied to a securities purchase agreement with investor David E. Lazar.

## SEC filing metadata
- accession: 0001493152-26-002850
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2026-01-20T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315226002850/0001493152-26-002850-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315226002850/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-002850
- JSON: https://secwatch.observer/filing/0001493152-26-002850.json
- Plain text: https://secwatch.observer/filing/0001493152-26-002850.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.